Abstract:Neurodegenerative diseases are part of the central nervous system (CNS) disorders that indicate their presence with neuronal loss, neuroinflammation, and increased oxidative stress. Several pathophysiological factors and biomarkers are involved in this inflammatory process causing these neurological disorders. The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is an inflammation element, which induced transcription and appears to be one of the important players in physiological procedures, especially nervous disorders. NF-κB can impact upon series of intracellular actions and induce or inhibit many inflammation-related pathways. Multiple reports have focused on the modification of NF-κB activity, controlling its expression, translocation, and signaling pathway in neurodegenerative disorders and injuries like Alzheimer's disease (AD), spinal cord injuries (SCI), and Parkinson's disease (PD). Curcumin has been noted to be a popular anti-oxidant and anti-inflammatory substance and is the foremost natural compound produced by turmeric. According to various studies, when playing an anti-inflammatory role, it interacts with several modulating proteins of long-standing disease signaling pathways and has an unprovocative consequence on pro-inflammatory cytokines. This review article determined to figure out curcumin's role in limiting the promotion of neurodegenerative disease via influencing the NF-κB signaling route. Preclinical studies were gathered from plenty of scientific platforms including PubMed, Scopus, Cochrane, and Google Scholar to evaluate this hypothesis. Extracted findings from the literature review explained the repressing impact of Curcumin on the NF-κB signaling pathway and, occasionally down-regulating the cytokine expression. Yet, there is an essential need for further analysis and specific clinical experiments to fully understand this subject.

Curcuminoids as natural modulators of necroptosis: therapeutic implications

Necroptosis in Inflammatory Bowel Disease and Other Intestinal Diseases

Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.

Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target

The regulating effect of curcumin on NF-κB pathway in neurodegenerative diseases: a review of the underlying mechanisms

Curcumin: a modulator of inflammatory signaling pathways in the immune system

Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells

Necroptosis inhibitors: mechanisms of action and therapeutic potential

A narrative review of the role of necroptosis in liver disease: a double-edged sword

The Potential Role of Necroptosis in Clinical Diseases (Review)

Curcumin and Ferroptosis: a Promising Target for Disease Prevention and Treatment

Ancient Drug Curcumin Impedes 26S Proteasome Activity by Direct Inhibition of Dual-Specificity Tyrosine-Regulated Kinase 2

Mitochondrial Mechanisms of Necroptosis in Liver Diseases

Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression

Necroptosis: a regulated inflammatory mode of cell death

The role of necroptosis in neurosurgical diseases.

Rip1/Rip3-Regulated Necroptosis As A Target For Multifaceted Disease Therapy (Review)

Targeting the Akt signaling pathway: Exploiting curcumin's anticancer potential

Necroptosis in health and diseases

Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management

Protein phosphorylation and kinases: Potential therapeutic targets in necroptosis